Orexigen Therapeutics, Inc.·4

Jul 18, 4:54 PM ET

DOVEY BRIAN H 4

4 · Orexigen Therapeutics, Inc. · Filed Jul 18, 2017

Insider Transaction Report

Form 4
Period: 2017-07-14
DOVEY BRIAN H
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-07-14+5,0005,000 total
    Exercise: $2.88Exp: 2027-07-13Common Stock (5,000 underlying)
Footnotes (1)
  • [F1]1/12th of the original number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest in equal monthly installments over 12 months following the vesting commencement date of July 14, 2017, subject to the Reporting Person's continuing service on the Issuer's Board of Directors through each such date, and subject to the terms of the Stock Option Agreement in the event of a change of control of the Issuer.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT